FDA Warns Novo Nordisk Broke Safety Reporting Rules MedNews
THURSDAY, March 12, 2026 Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government.In
With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
The planned trial targets adults with Stage 2-4 chronic kidney disease and will track kidney function and inflammation markers. Recruitment starts after listing. Post Views: 1